Gynecologic care after hematopoietic cell transplantation: a call to action to include gynecologists in the transplant team
Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD
Is ‘informed consent’ an ‘understood consent’ in hematopoietic cell transplantation?
Children as hematopoietic cell donors in research: when is it approvable?
Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL
Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation
Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis
Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies
Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients
DLI after haploidentical BMT with post-transplant CY
A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent
Impact of CD34+ cell dose in children who receive unrelated PBSCT with in vivo T-cell depletion for hematologic malignancies
Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML
Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study
The impact of center accreditation on hematopoietic cell transplantation (HCT)
Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure
Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent nonrelapse mortality
Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT
Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT
Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome
Retrospective comparison of allogeneic vs autologous transplantation for diffuse large B-cell lymphoma with early relapse or primary induction failure
Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient
Sclerodermatous chronic GVHD in patients receiving tyrosine kinase inhibitors after allogeneic hematopoietic cell transplantation
Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT
Fecal microbiota transplant after hematopoietic SCT: report of a successful case
Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients
Nasal GVHD
KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation
Severe chronic psychosis after allogeneic SCT from a schizophrenic sibling
Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY
Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma
Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit